Treatment Registry

Company

ElleS

ElleS publishes unspecified GLP-1 at $179 a month — Starting price.

  • 1 program
  • 1 molecule
  • 1 reading

Read from ellesvi.com on September 2, 2026. This page records what the company publishes. It is not a review and takes no position on the company.

Go to ElleS

Visit ElleS

We earn nothing from this link. ElleS has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

What it costs

first month, including the required fees on record · Starting price

Terms

Not yet checked: pharmacy, membership, consultation fee and states.

Terms can differ between this company’s programs; each entry carries its own.

Programs

EntryProviderPer month
at its shortest term
Link
TR-0621ElleS$179
Starting price
Record

Notes

Recorded against this company rather than one program.

September 2, 2026

  1. 1. The company is ElleS Care LLC per the footer. The site never names semaglutide or tirzepatide anywhere in the crawled text — treatment is described only as 'GLP-1 Medication' — so drug is recorded as unspecified GLP-1. $179 is explicitly listed as including the medication itself ('GLP-1 Medication' is one of the line items under 'What's included?'), so it is recorded as a price, not a membership fee. The /category/weight-loss product listing page and the /legal/terms-of-service page are both client-rendered with essentially no server-side text (283 and 2,254 chars respectively, almost all nav/footer boilerplate), so no product-level drug breakdown, states list, or explicit cancellation/refund policy could be read; the terms page links out to an external Freshdesk article (support.careglp.com) that 404'd.

Before you act

Cite this

Treatment Registry. (2026). ElleS: recorded programs and prices. Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/elles